WELCOME TO The PHARMACEUTICAL REPORT
Newsletter | Member Login | Signup
Home > Resources > Whitepapers > Advanced Biopharmaceutical Manufacturing: An Evolution Underway
I'm For Real
Enter your details once to access all our information and resources
Quotient Bioresearch is now Pharmaron. To keep up to date with radiolabelled sciences news at Pharmaron, please follow Pharmaron, Radiolabelled Sciences Division.
whitePaper | January 20, 2023
Understanding an antibody’s mechanism of action (MOA) is critical to its clinical success. Not only does MOA have a large impact on safety and efficacy.
whitePaper | February 24, 2023
A new way of thinking and working has evolved for the discovery of therapeutic antibodies. Until recently, large numbers of antibodies were generated, only for a relatively small fraction to be sampled and engineered for further lead generation.
whitePaper | November 10, 2022
We know people don’t like to be sold to. And in the so-called ‘attention economy’, it is more important than ever that your business can utilise meaningful marketing and advertising practices to engage with your customers and secure their attention.
whitePaper | May 5, 2022
welcome to pharmaprojects'2022 review of trends in pharmaceutical R&D for 30 year now, I've been taking an anual look at the evloution of pharma
whitePaper | September 16, 2022
T wice a year, we survey the cell and gene therapy landscape and ARM’s initiatives to advance the sector and provide an update to our members.
whitePaper | March 15, 2022
Successes in 2021 – New active substance drug launches
Conference
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE